397 related articles for article (PubMed ID: 33206398)
1. LRRK2 at the pre-synaptic site: A 16-years perspective.
Pischedda F; Piccoli G
J Neurochem; 2021 Apr; 157(2):297-311. PubMed ID: 33206398
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2.
Belluzzi E; Greggio E; Piccoli G
Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 along the Golgi and lysosome connection: a jamming situation.
Piccoli G; Volta M
Biochem Soc Trans; 2021 Nov; 49(5):2063-2072. PubMed ID: 34495322
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
Nguyen M; Krainc D
Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
[TBL] [Abstract][Full Text] [Related]
6. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 and membrane trafficking: nexus of Parkinson's disease.
Hur EM; Jang EH; Jeong GR; Lee BD
BMB Rep; 2019 Sep; 52(9):533-539. PubMed ID: 31383252
[TBL] [Abstract][Full Text] [Related]
8. Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis.
Heaton GR; Landeck N; Mamais A; Nalls MA; Nixon-Abell J; Kumaran R; Beilina A; Pellegrini L; Li Y; ; Harvey K; Cookson MR
Neurobiol Dis; 2020 Jul; 141():104948. PubMed ID: 32434048
[TBL] [Abstract][Full Text] [Related]
9. The LRRK2 N-terminal domain influences vesicle trafficking: impact of the E193K variant.
Marku A; Carrion MDP; Pischedda F; Marte A; Casiraghi Z; Marciani P; von Zweydorf F; Gloeckner CJ; Onofri F; Perego C; Piccoli G
Sci Rep; 2020 Mar; 10(1):3799. PubMed ID: 32123243
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.
Marte A; Russo I; Rebosio C; Valente P; Belluzzi E; Pischedda F; Montani C; Lavarello C; Petretto A; Fedele E; Baldelli P; Benfenati F; Piccoli G; Greggio E; Onofri F
J Neurochem; 2019 Aug; 150(3):264-281. PubMed ID: 31148170
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 regulates synaptic vesicle endocytosis.
Shin N; Jeong H; Kwon J; Heo HY; Kwon JJ; Yun HJ; Kim CH; Han BS; Tong Y; Shen J; Hatano T; Hattori N; Kim KS; Chang S; Seol W
Exp Cell Res; 2008 Jun; 314(10):2055-65. PubMed ID: 18445495
[TBL] [Abstract][Full Text] [Related]
12. The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions.
Carrion MDP; Marsicano S; Daniele F; Marte A; Pischedda F; Di Cairano E; Piovesana E; von Zweydorf F; Kremmer E; Gloeckner CJ; Onofri F; Perego C; Piccoli G
Sci Rep; 2017 Jul; 7(1):5377. PubMed ID: 28710481
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
Rassu M; Biosa A; Galioto M; Fais M; Sini P; Greggio E; Piccoli G; Crosio C; Iaccarino C
J Cell Mol Med; 2019 Dec; 23(12):8505-8510. PubMed ID: 31560168
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 and the Endolysosomal System in Parkinson's Disease.
Erb ML; Moore DJ
J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
[TBL] [Abstract][Full Text] [Related]
15. A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals.
Soukup SF; Kuenen S; Vanhauwaert R; Manetsberger J; Hernández-Díaz S; Swerts J; Schoovaerts N; Vilain S; Gounko NV; Vints K; Geens A; De Strooper B; Verstreken P
Neuron; 2016 Nov; 92(4):829-844. PubMed ID: 27720484
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.
Brzozowski CF; Hijaz BA; Singh V; Gcwensa NZ; Kelly K; Boyden ES; West AB; Sarkar D; Volpicelli-Daley LA
Acta Neuropathol Commun; 2021 Nov; 9(1):180. PubMed ID: 34749824
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.
Piccoli G; Condliffe SB; Bauer M; Giesert F; Boldt K; De Astis S; Meixner A; Sarioglu H; Vogt-Weisenhorn DM; Wurst W; Gloeckner CJ; Matteoli M; Sala C; Ueffing M
J Neurosci; 2011 Feb; 31(6):2225-37. PubMed ID: 21307259
[TBL] [Abstract][Full Text] [Related]
18. The role of LRRK2 in cytoskeletal dynamics.
Civiero L; Cogo S; Biosa A; Greggio E
Biochem Soc Trans; 2018 Dec; 46(6):1653-1663. PubMed ID: 30467120
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.
Matta S; Van Kolen K; da Cunha R; van den Bogaart G; Mandemakers W; Miskiewicz K; De Bock PJ; Morais VA; Vilain S; Haddad D; Delbroek L; Swerts J; Chávez-Gutiérrez L; Esposito G; Daneels G; Karran E; Holt M; Gevaert K; Moechars DW; De Strooper B; Verstreken P
Neuron; 2012 Sep; 75(6):1008-21. PubMed ID: 22998870
[TBL] [Abstract][Full Text] [Related]
20. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
